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PURPOSE. Recent evidence suggests structural changes distal to the inner retina in multiple
sclerosis (MS) patients. The functional correlates of these proposed structural abnormalities
remain unclear. We investigated outer retinal function and structure in MS patients, and
quantified to what extent outer retinal structure influenced function in these patients.
METHODS. Outer retinal function was assessed using the full-field and multifocal electroret-
inogram (ERG/MF-ERG), whereas retinal structure was assessed using spectral-domain optical
coherence tomography (OCT). Results were compared with preexisting normative data. The
relationships between electrophysiology parameters and the OCT values corresponding to
the proposed cellular origins of the ERG and MF-ERG were analyzed.
RESULTS. Most electrophysiological responses were delayed in MS patients, independently of optic
neuritis (ON). Inner retinal thickness and volumes were reduced, and inner nuclear layer volume
marginally increased, in eyes with previous ON; all other OCT parameters were normal. OCT
results correlated with ERG amplitudes, but not with ERG peak times or any MF-ERG parameters.
CONCLUSIONS. We recorded outer retinal dysfunction without detectable abnormalities of the
corresponding retinal layers in MS patients, not ascribable to retrograde degeneration
following ON. The findings complement a growing body of literature reporting primary
retinal abnormalities distal to the ganglion cell–inner plexiform layer complex in MS patients,
with our data suggesting that this may be a more widespread phenomenon than previously
thought. ERG may be of more utility in detecting retinal dysfunction in MS patients than MF-
ERG. Analysis of peak times, rather than response amplitudes, is recommended.
Keywords: retina, multiple sclerosis, optic neuritis, electrophysiology, optical coherence
tomography
Multiple sclerosis (MS) is a complex, heterogeneousneurologic disorder characterized by inflammatory demy-
elination and degeneration within the central nervous system.
The near-ubiquity of visual system involvement in MS1,2 and
unique accessibility of the retina as a site for viewing
unmyelinated axons and neurons in vivo have driven interest
in the afferent visual pathway as a clinical model for MS
research.3 Accordingly, spectral-domain optical coherence
tomography (OCT) has become a widely used tool to assess
neuronal and axonal degeneration in MS patients.4 However,
OCT remains a structural measure; it is currently not possible to
measure retinal neuronal function using OCT in a manner
analogous to functional magnetic resonance imaging (MRI) of
the brain. Instead, retinal function can be measured using
electrophysiology, particularly the ERG and its variants. For
example, it is possible to measure the function of the
photoreceptors and bipolar cells from the entire or localized
areas of central retina using the ERG,5,6 and multifocal ERG (MF-
ERG),7 respectively.
In recent years, the question of retinal pathology distal to
the inner retina in MS has gained increasing interest. For
example, postmortem histologic analysis has revealed evidence
of atrophy of the inner nuclear layer (INL) in addition to the
inner retinal layers (both the retinal ganglion cells and their
axons, found in the retinal nerve fiber layer [RNFL]).8
Additionally, INL has recently been described as responding
dynamically to disease activity and treatment; untreated MS
patients were found to have a greater INL volume than healthy
control subjects, yet this volume appeared to normalize
following successful disease-modifying therapy (as evidenced
by no clinical relapses or new MRI lesions during the follow-up
period).9 It has also been proposed that an atypical subset of
MS patients may exhibit thinning of the INL and outer nuclear
layer (ONL) without corresponding inner retinal changes.10
The functional correlates of these proposed structural changes
remain unknown; although electroretinographic studies of MS
patients have been previously published,11–13 results vary
considerably between studies, and to date no published work
has examined the relationships between OCT-derived outer
retinal structure and function in MS.
Against this background, we have embarked on a longitu-
dinal study of retinal structure and function in MS patients.
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Here, we present the results of a cross-sectional analysis of
baseline measurements. We aimed to ascertain whether outer
retinal function and structure are abnormal in a representative
MS and clinically isolated syndrome (CIS) cohort, and to
investigate whether retinal function is related to OCT-derived
structural measures in MS patients. Finally, we aimed to
generate hypotheses as to which (if any) electrophysiological
parameters are most suitable for further analysis.
MATERIALS AND METHODS
All MS patients were participants in the prospective longitu-
dinal Heterogeneity of Multiple Sclerosis (HETOMS) study at
the University Hospital Zurich and University of Zurich who
consented in writing to additionally participate in a longitudi-
nal ophthalmologic substudy. Inclusion criteria for the
substudy were as follows: confirmed diagnosis of MS or
CIS,14 and age at enrollment 18 to 65 years. Exclusion criteria
were as follows: refractive errors >6 diopters, coexisting
ocular or neurologic disease other than MS, and diabetes
mellitus. The study adhered to the tenets of the Declaration of
Helsinki and was approved by the Cantonal Ethics Committee
of Zurich (EC-No.2013-0001). All patients received a compre-
hensive eye examination including best-corrected high- and
low-contrast visual acuity using Early Treatment Diabetic
Retinopathy Study (ETDRS) and 2.5% contrast Sloan charts,
respectively, anterior segment and mydriatic fundus examina-
tion by a senior ophthalmologist (CG-K), spectral-domain OCT
(Spectralis, Heidelberg Engineering, Heidelberg, Germany),
ERG, and MF-ERG. Although the study was primarily focused
on the outer retina, pattern-reversal visual-evoked potentials,
pattern ERG, and the photopic negative response were also
measured (as described in Supplementary Data) to assess and
compare visual pathway and retinal ganglion cell function.
Optical Coherence Tomography
High-resolution circumpapillary scans (128 diameter; 100
Automatic Real-time Tracking [ART] scans averaged) were
aligned to the visible center of the optic nerve head, whereas
high-resolution volume scans (308 vertical by 158 horizontal
pattern composed of 19 vertically oriented sections, each
separated by 240 lm, 25 ART) were centered on the fovea.
After ensuring that all acquired OCT scans were of acceptable
quality as defined by the OSCAR-IB criteria,15 the volume scans
were automatically segmented and manually verified using
proprietary software (Heidelberg Engineering). This enabled
visualization and quantification of the macular ganglion cell–
inner plexiform layer complex (GC-IPL), INL, outer plexiform
layer (OPL), ONL, and photoreceptor (PR) complex for each eye
(Fig. 1a). Each of the macular OCT parameters was summarized
as the volume (in mm3) of each layer or complex measured over
the 1, 2.22, and 3.45 mm ETDRS grid. RNFL thickness
measurements were obtained from the circumpapillary OCT
scan (Fig. 1b); the global thickness (RNFL-G), averaged from all
sectoral measurements, was analyzed, along with thickness in
the temporal (RNFL-T) and papillomacular bundle (RNFL-PMB)
sectors as implemented in the software (Fig. 1c).
Electrophysiology
ERG and MF-ERG were recorded using gold-plated skin
electrodes and single-use DTL (Dawson, Trick, and Litzkow)-
type recording electrodes (Diagnosys LLC, Lowell MA, USA)
according to published standards of the International Society
for Clinical Electrophysiology of Vision5,16 on an Espion system
(Diagnosys LLC). Medical mydriasis was accomplished using
topical 0.5% tropicamide and 5% phenylephrine. Before
applying the skin electrodes (reference electrodes at the
ipsilateral outer canthi; ground electrode at the center of the
forehead), patients’ skin was first cleaned and then scrubbed
using OneStep AbrasivPlus paste (HþH Medizinprodukte GbR,
Mu¨nster, Germany) to minimize electrical impedance during
recording. To prevent potential patient discomfort, 0.4%
oxybuprocaine was instilled before positioning the DTL
electrodes.
Before recording the ERG, patients were dark-adapted for
20 minutes. When this adaptation period was over, patients
were presented with 0.01 cd/m2 flashes (‘‘rod’’) followed by
3.0 cd/m2 flashes (‘‘rod-cone’’) to measure the responses of the
rod system and combined rod-cone systems, respectively.
When these measurements were complete, patients were
adapted to a rod-bleaching 30 cd/m2 light for 10 minutes
before being presented with 3.0 cdm/2 light, both flickering
(30-Hz frequency; ‘‘cone flicker’’) and single flashes (‘‘cone’’).
All stimuli were presented via a full-field stimulator with
diffusor, of 4-ms duration, and composed of white light.
Multiple responses were recorded to verify reproducibility,
which were averaged to produce the final responses from
which parameters for analysis were derived (rod and rod-cone
ERG: average of 6 responses; flicker ERG: average of 26
responses; cone ERG: average of 24 responses).
The MF-ERG was recorded in normal room illumination
following the ERG using an achromatic 61-hexagon stimulus
array covering approximately 508 of the central visual field.
Hexagons had a luminance of either 400 cd/m (‘‘on’’) or 0.0
cd/m2 (‘‘off’’), with the on/off string of each hexagon
determined according to a 14-bit M-sequence. The base period
for stimulus presentation was 13.3 ms (equivalent to 75 Hz)
and the recordings were bandpass filtered (10–100 Hz) to
remove extraneous electrical noise.16 Each recording session
lasted 30 seconds, with a minimum of eight sessions required
to complete the MF-ERG recording.
From the ERG, the a-wave, b-wave, and flicker peak times
and amplitudes were ascertained for each eye and each
stimulus condition (Figs. 1d–g) with the exception of the
dark-adapted 0.01 (‘‘rod’’) a-wave, which is not recommended
for quantitative analysis.5 Ratios of the rod-cone and cone b-
wave/a-wave amplitudes were calculated. MF-ERG P1 peak
times and amplitudes were analyzed using the concentric ring
method16 (Figs. 1h, 1i).
Statistical Analysis
Electrophysiological and OCT results were compared with our
preexisting clinical normative databases, comprising data
acquired on-site from single eyes of healthy individuals using
the same devices used in the study. From these databases, all
available healthy subjects of comparable age to the MS cohort
were included in the analysis (ERG: n¼ 49 subjects; MF-ERG: n
¼ 36 subjects; OCT: n¼ 38 subjects). The age distributions of
the MS cohort and the subjects contributing normative data for
the ERG, MF-ERG, and OCT analyses are shown in Table 1. Two
statistical analyses were performed: first, the functional
(electrophysiological) and structural (OCT) results were
compared by category (MS versus normal) and optic neuritis
(ON) history (positive versus negative) using generalized
estimating equation (GEE) models to account for the intereye
dependency of within-subject measurements.17,18 Second, the
relationships between ERG and MF-ERG parameters and their
presumed structural correlates were quantified in MS patients
only, using GEE models otherwise identical to those used in the
group comparison. All analyses were adjusted for age. The
reported confidence intervals for each coefficient are based on
robust standard errors.
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Current knowledge as summarized elsewhere5 implicates
the ERG a-wave as being generated mostly by the photore-
ceptors (the nuclei of which are found in the ONL) with
contributions from the bipolar cells (the nuclei of which are
found in the INL), with the b-wave being generated mostly by
bipolar cells. The P1 component of the MF-ERG is also
generated mostly by the bipolar cells.7 Therefore, the GEE
models quantified the effect of ONL, INL, PR volumes, and
ON history on the ERG a-waves, as well as INL and OPL
volume and ON history on the ERG b-waves, 30-Hz flicker
response peak, and MF-ERG P1 values. OPL was included in
the b-wave analyses due to its location as the site of bipolar
synaptic terminals; however, IPL was not included in the
analyses due to the difficulty in reliably distinguishing it from
the adjacent ganglion cell layer (GCL; GCL and IPL are
aggregated to GC-IPL in the present work for the same
reason).19–21 In every case, the Benjamini-Hochberg proce-
dure was applied to the P values to correct for multiple
testing.22 P values <0.01 were considered strong evidence of
an effect of the pertaining statistical parameter, whereas P
values between 0.01 and 0.05 and between 0.05 and 0.10
were considered to represent good and mild evidence,23
respectively; all other P values were considered nonsignifi-
cant. All analyses were performed within R version 3.3.124
using the geepack library (version 1.2-1).25
FIGURE 1. High-resolution macula OCT scan illustrating the retinal layers and complexes included in the analysis (a). Circumpapillary OCT scans
were centered on the visible center of the optic nerve head (b). Analysis of circumpapillary RNFL thickness (left eye). Values for the G, T, and PMB
sectors were included in the analysis (c). Examples of rod (d), rod-cone (e), cone flicker (f), and cone (g) ERG waveforms, showing the a- and b-
waves and flicker peak. The amplitudes and peak times of these variables, with the exception of the rod a-wave parameters, were included in the
analysis, along with the ratios of the rod-cone and cone b- and a-wave amplitudes. Example of MF-ERG test using a 61-hexagon stimulus array; the
concentric rings used for averaging are color-coded for ease of interpretation (h). Averaging the traces results in five normalized waveforms, color-
coded to match the traces in (h). The normalized P1 amplitude and P1 peak time of each of the resultant waveforms (1–5) were included in the
analysis (i).
TABLE 1. Age Distributions of the MS Cohort (MS) and the Healthy
Individuals Contributing Normative Data for the ERG (Normative ERG),
MF-ERG (Normative MF-ERG), and OCT (Normative OCT)
n
Mean
Age, y SD
Median
Age, y IQR
MS 32 35.8 10.6 35.0 27.0–44.2
Normative ERG 49 35.4 10.8 31.0 28.0–43.0
Normative MF-ERG 36 36.9 12.5 34.5 27.3–50.8
Normative OCT 38 35.6 12.5 29.5 26.0–46.0
The distributions are described by the mean and SD, and by the
median and the IQR. All values are in years.
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RESULTS
A total of 32 subjects (22 female) had completed the initial
examination of the longitudinal study, the results of which
were analyzed on a cross-sectional basis. Of the patient cohort,
19 had relapsing-remitting MS, 11 CIS, and two primary
progressive MS (PPMS). Median age was 35 years (range, 21–59
years), whereas median Enhanced Disability Status Scale
(EDSS) score was 1.0 (range, 0.0–4.0); median disease duration
(as defined by time since first symptoms) was 18.5 months
(range, 3–324). Nineteen patients had a clinical history of ON,
four of whom had been affected in both eyes sequentially or
simultaneously; however, none of the patients had experi-
enced an ON event within the 3 months before examination.10
Nineteen patients were receiving disease-modifying therapy at
the time of the examination. No patients had myelinated retinal
nerve fibers visible on OCT or fundus examination. The
demographic characteristics of the patient cohort are shown in
more detail in Supplementary Table S1 (Supplementary Data).
One patient had minimal residual traces of microcystic macular
edema (MMO) in one eye (with a history of ON 30 months
previously), which were not unambiguously visible on two
adjacent OCT slices and therefore did not meet published
MMO diagnostic criteria,26 and so we did not exclude this
patient from OCT analysis; no other patients had visible traces
of MMO. Another patient had an exotropia; therefore, data
pertaining to this eye were excluded from analysis. One patient
was unable to perform the MF-ERG and for another patient it
was not possible to perform OCT. In total, 63 eyes of 32
patients were analyzed for the ERG, and 61 eyes of 31 patients
for both the MF-ERG and OCT. Mean and median values of all
ERG, MF-ERG, and OCT parameters are given in Tables 2, 3,
and 4, respectively, for both MS and normative cohorts. Mean
high- and low-contrast visual acuity (with SD) were 0.088 6
0.078 logMAR and 0.464 6 0.194 logMAR, respectively;
median values were 0.10 logMAR and 0.33 logMAR,
respectively.
The results of the electrophysiology analyses are shown in
Tables 5 and 6. Those conditions for which strong, good, or
mild evidence of difference between MS patients and normal
values are shown in Figures 2 and 3. For the ERG (Table 5; Fig.
2), four of seven measures of peak time showed strong
evidence of a difference between MS patients and normative
data (rod-cone a-wave, cone flicker, cone a-wave, and cone b-
wave), whereas there was mild evidence for a difference in rod-
cone b-wave peak time. Inspection of the data confirmed that
this difference was due to longer peak times in the MS group
(Table 2; Figs. 2c, 2e–h). All of these longer peak times
comprised part of the cone or mixed rod/cone response. No
differences in rod b-wave peak time were observed. Strong
(rod b-wave), good (rod-cone a-wave), and mild (rod-cone b-
wave) evidence was observed for amplitude differences
between MS patients and normative data; rod-cone a-waves
were lower in amplitude (Fig. 2a), and rod b-waves and rod-
cone b-waves of higher amplitude (Figs. 2b, 2d), in MS patients.
No other differences in ERG amplitudes were observed. We did
not find evidence for a difference in rod-cone or cone a-wave/
b-wave ratios between MS patients and normative data. MF-
ERG results (Table 6; Fig. 3) showed good (rings 3 and 5) and
mild (rings 2 and 4) evidence for prolonged P1 peak times in
MS patients, without any differences in response amplitudes.
Both ERG and MF-ERG results did not differ in eyes with
previous ON compared with those without previous ON.
Analysis of the OCT data (Table 7; Fig. 4) showed no
significant differences between MS patients and normative data
TABLE 2. Results of ERG Examinations in MS Patients (MS) and Healthy Subjects Previously Examined in our Clinic (Normative)
ERG Variable Category n Mean SD Median IQR
Rod b-wave AMP, lV Normative 49 339.518 83.826 342.800 284.900 to 382.300
MS 63 387.778 70.877 395.400 339.350 to 440.200
Rod b-wave PEAK, ms Normative 49 77.969 6.937 78.000 74.000 to 80.500
MS 63 80.365 7.279 80.000 74.500 to 84.750
Rod-cone a-wave AMP, lV Normative 49 298.996 65.828 294.000 332.700 to 259.900
MS 63 329.063 67.921 328.600 371.150 to 279.850
Rod-cone a-wave PEAK, ms Normative 49 14.765 0.511 15.000 14.500 to 15.000
MS 63 15.286 0.711 15.500 15.000 to 15.500
Rod-cone b-wave AMP, lV Normative 49 470.598 112.288 483.100 397.500 to 542.900
MS 63 518.843 86.434 508.400 453.350 to 559.250
Rod-cone b-wave PEAK, ms Normative 49 52.561 3.813 52.500 50.000 to 55.000
MS 63 54.548 3.504 54.000 52.000 to 57.000
Cone flicker AMP, lV Normative 49 136.356 32.964 137.900 114.800 to 151.500
MS 63 141.040 33.411 134.300 120.100 to 164.850
Cone flicker PEAK, ms Normative 49 26.929 1.271 26.500 26.000 to 28.000
MS 63 28.444 1.856 28.500 27.500 to 29.500
Cone a-wave AMP, lV Normative 49 47.946 13.096 47.600 56.350 to 39.370
MS 63 52.435 12.894 54.610 61.665 to 41.440
Cone a-wave PEAK, ms Normative 49 13.929 0.685 14.000 13.500 to 14.500
MS 63 14.468 0.647 14.500 14.000 to 15.000
Cone b-wave AMP, lV Normative 49 176.934 40.406 177.700 148.100 to 202.800
MS 63 182.117 34.745 179.000 157.100 to 204.900
Cone b-wave PEAK, ms Normative 49 30.051 1.312 30.000 29.000 to 31.000
MS 63 31.833 1.818 32.000 30.500 to 33.000
Rod-cone b/a-wave ratio Normative 49 1.584 0.251 1.565 1.418 to 1.695
MS 63 1.602 0.215 1.557 1.488 to 1.661
Cone b/a-wave ratio Normative 49 3.787 0.653 3.721 3.242 to 4.288
MS 63 3.573 0.636 3.427 3.093 to 4.072
For each ERG amplitude (AMP) and peak time (PEAK) parameter, the number of eyes analyzed (n) is shown, along with values for mean, SD,
median, and IQR. AMP values are given in microvolts, and PEAK in milliseconds.
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for any of the measured retinal layers/complexes. However,
strong evidence of difference between eyes with and without
previous ON was found for RNFL-G, -T, and -PMB, as well as GC-
IPL; mild evidence of difference was found for the INL. All
measures of RNFL and GC-IPL showed reduced thickness or
volume after ON (Figs. 4a–d), whereas INL volume was slightly
increased (Fig. 4e).
Assessment of the relationships between retinal function
and structure in MS patients showed strong (rod-cone a-wave)
to good (cone a-wave; rod-cone and cone b-waves) evidence
for an association between ERG amplitudes and ONL (a-waves)
and INL (b-waves). No significant associations with ERG peak
times or with any MF-ERG parameters (data not shown) were
observed; all analyses pertaining to PR and OPL were also
nonsignificant. We found mild (P ¼ 0.098) evidence for an
influence of ON history on rod-cone a-wave amplitudes; all
other P values pertaining to ON history were nonsignificant.
The results of this analysis are summarized in Table 8.
Two patients had PPMS (Supplementary Table S1), which is
phenotypically distinct from other forms of MS.14 We therefore
repeated all GEE analyses previously described with both PPMS
patients excluded, to exclude the remote possibility that their
inclusion may have unduly influenced results; the pattern of
results was unchanged (data not shown).
DISCUSSION
Our study presents strong evidence for altered outer retinal
function in patients with MS. The results did not provide
evidence for an influence of ON on the ERG and MF-ERG in our
TABLE 3. Results of MF-ERG Examinations in MS Patients (MS) and Healthy Subjects Previously Examined in Our Clinic (Normative)
MF-ERG Variable Category n Mean SD Median IQR
Ring 1 AMP, nV/deg2 Normative 36 45.392 12.452 44.950 37.625–53.250
MS 61 45.843 10.951 45.900 38.900–51.500
Ring 1 PEAK, ms Normative 36 33.103 0.957 33.300 32.400–34.100
MS 61 33.502 1.299 33.300 32.400–34.100
Ring 2 AMP, nV/deg2 Normative 36 24.308 6.533 22.850 19.800–29.300
MS 61 24.941 4.843 24.900 21.700–27.700
Ring 2 PEAK, ms Normative 36 31.956 1.134 31.600 30.800–32.400
MS 61 32.693 1.167 32.400 32.400–33.300
Ring 3 AMP, nV/deg2 Normative 36 13.942 3.641 13.350 11.150–15.950
MS 61 14.495 2.811 14.200 12.400–16.600
Ring 3 PEAK, ms Normative 36 31.178 1.130 31.200 30.600–31.800
MS 61 31.946 1.207 31.600 31.600–32.400
Ring 4 AMP, nV/deg2 Normative 36 9.739 2.362 9.250 8.200–11.200
MS 61 10.431 2.155 10.200 9.000–11.200
Ring 4 PEAK, ms Normative 36 31.164 1.042 30.800 30.800–31.600
MS 61 31.852 1.277 31.600 30.800–32.400
Ring 5 AMP, nV/deg2 Normative 36 8.425 2.164 7.850 6.700–10.125
MS 61 8.526 1.999 8.200 7.500–9.300
Ring 5 PEAK, ms Normative 36 31.139 0.999 30.800 30.600–31.600
MS 61 31.982 1.358 32.400 30.800–32.400
For each MF-ERG amplitude (AMP) and peak time (PEAK) parameter calculated over five concentric rings (Fig. 1h), the number of eyes analyzed
(n) is shown, along with values for mean, SD, median, and IQR. AMP values are given in nanovolts per square degree, and PEAK values in
milliseconds.
TABLE 4. Results of OCT Examinations in MS Patients (MS) and Healthy Subjects Previously Examined in our Clinic (Normative)
OCT Variable Category n Mean SD Median IQR
RNFL-G, lm Normative 38 101.368 6.136 100.500 97.000–105.000
MS 61 96.180 14.874 98.000 91.000–106.000
RNFL-T, lm Normative 38 73.000 6.998 74.000 67.250–77.000
MS 61 63.393 16.128 64.000 54.000–74.000
RNFL-PMB, lm Normative 38 55.368 5.592 54.000 51.000–59.000
MS 61 48.066 12.128 49.000 42.000–56.000
GC-IPL, mm3 Normative 38 0.839 0.055 0.850 0.790–0.878
MS 61 0.778 0.123 0.800 0.700–0.870
INL, mm3 Normative 38 0.351 0.035 0.350 0.340–0.370
MS 61 0.352 0.032 0.350 0.330–0.370
OPL, mm3 Normative 38 0.292 0.038 0.290 0.270–0.310
MS 61 0.298 0.042 0.290 0.270–0.310
ONL, mm3 Normative 38 0.698 0.070 0.690 0.670–0.718
MS 61 0.671 0.078 0.680 0.620–0.740
PR, mm3 Normative 38 0.774 0.019 0.770 0.760–0.790
MS 61 0.766 0.021 0.770 0.750–0.780
For each structural parameter, the number of eyes analyzed (n) is shown, along with values for mean, SD, median, and IQR. RNFL-G, RNFL-T, and
RNFL-PMB values are given in micrometers, whereas volumes of the GC-IPL, INL, OPL, ONL, and PR over the 1-, 2.22-, and 3.45-mm ETDRS grid are
given in cubic millimeters.
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patient cohort, which is consistent with outer retinal
dysfunction as a primary manifestation of MS. Although this
interpretation of our data concords with previous ERG (but not
MF-ERG) findings in MS patients without previous ON,11 we
are nevertheless unable to exclude the possibility that the
relatively modest sample size of the MS ON subgroups in our
study may have contributed to this negative result. Previous
work has proposed primary retinal pathology in a subset of MS
patients with atypical OCT findings of the outer retina
(representing approximately 10% of the patient population at
that center)10; our results extend this finding and suggest that
effects of MS on the outer retina may be a more widespread
phenomenon than previously thought. Despite our OCT
device being capable of acquiring scans with an optical axial
resolution of 7 lm,27 we did not record any changes to the
corresponding retinal layers due to MS.
Previous work examining the ERG in MS patients has
produced apparently contradictory findings, with some au-
thors reporting normal ERG results28–30 and others a range of
abnormalities.11–13,31–34 Significantly, those studies that report-
ed normal ERG findings in MS patients analyzed only response
amplitudes, with no peak time values presented.28–30 Previous
studies showing changes to the peak time of the cone12,34 or
mixed rod/cone11,34 ERG responses are unanimous in record-
ing delayed responses relative to normative values, as
described here.
With regard to response amplitudes, previous results are
mixed, with studies showing normal,28–30 reduced,31,32 or
increased13 ERG amplitudes in MS patients relative to control
subjects; none of these studies also analyzed peak time. In this
context, our results showing mostly normal amplitudes (with
increased or decreased amplitudes for some conditions) are
not contrary to previous studies. We are unaware of any
previous analysis of b-wave/a-wave amplitude ratios in MS
patients; in the present work, these ratios did not differ
significantly between MS patients and normative data. It seems
that ERG peak times are more likely than response amplitudes
or b-wave/a-wave amplitude ratios to be abnormal in MS
patients and may thus represent a more sensitive indicator of
outer retinal dysfunction.
To our knowledge, the present study is the first to show MF-
ERG abnormalities in a typical MS cohort. In MS patients
without previous ON, MF-ERG has been recorded as normal,11
whereas five of seven patients with atypical OCT findings
(reduced macular thickness in the presence of normal RNFL
and GC-IPL thickness) were found to exhibit reduced P1
amplitudes.10 In contrast, our patient cohort (which was
mixed with regard to MS type and history of ON) was found to
have mostly prolonged P1 peak times without any significant
differences in P1 response amplitudes. No differences between
eyes with and without a history of ON were observed.
Abnormal P1 peak times suggest dysfunction of the on-bipolar
cells7 and are hypothesized to reflect damage between cone
inner segments and postsynaptic membranes of bipolar cells,35
although note that dysfunction confined to the photoreceptors
may also affect P1.35
These effects of MS are apparent at the level of the
photoreceptors and bipolar cells of the outer retina, the first-
and second-order retinal neurons, respectively. It is not
possible from our data to infer the physiological mechanisms
TABLE 5. Results of GEE Models for ERG Amplitude (AMP) and peak
time (PEAK) Variables According to MS Status (MS Versus Healthy) and
ON History (Positive Versus Negative), Adjusted for Age and Including
Coefficients, 95%-Wald Confidence Intervals (CI) of the Coefficients,
and Corrected P Values (Benjamini-Hochberg)
ERG Variable Covariate Coefficient 95% CI
P,
Corrected
Rod b-wave
AMP
MS status 52.145 19.856 to 84.434 0.008
ON history 9.936 41.626 to 21.754 0.746
Rod b-wave
PEAK
MS status 2.517 0.815 to 5.848 0.234
ON history 0.340 4.023 to 3.344 0.921
Rod-cone a-
wave AMP
MS status 37.731 67.559 to 7.903 0.040
ON history 22.323 6.511 to 51.158 0.530
Rod-cone a-
wave PEAK
MS status 0.530 0.258 to 0.802 0.001
ON history 0.061 0.261 to 0.140 0.746
Rod-cone b-
wave AMP
MS status 53.023 8.065 to 97.981 0.056
ON history 13.469 61.365 to 34.427 0.748
Rod-cone b-
wave PEAK
MS status 1.793 0.220 to 3.365 0.057
ON history 0.394 0.379 to 1.167 0.643
Cone flicker
AMP
MS status 6.773 7.303 to 20.850 0.518
ON history 4.446 12.312 to 3.420 0.643
Cone Flicker
PEAK
MS status 1.429 0.743 to 2.115 <0.001
ON history 0.198 0.212 to 0.607 0.643
Cone a-wave
AMP
MS status 4.672 10.245 to 0.900 0.193
ON history 0.401 5.121 to 5.922 0.921
Cone a-wave
PEAK
MS status 0.586 0.279 to 0.894 0.001
ON history 0.147 0.361 to 0.066 0.530
Cone b-wave
AMP
MS status 6.144 9.434 to 21.722 0.593
ON history 1.760 14.416 to 10.895 0.910
Cone b-wave
PEAK
MS status 1.629 0.861 to 2.396 <0.001
ON history 0.354 0.152 to 0.859 0.530
Rod-cone b-/a-
wave ratio
MS status 0.007 0.093 to 0.106 0.896
ON history 0.033 0.008 to 0.073 0.530
Cone b-/a-wave
ratio
MS status 0.226 0.515 to 0.064 0.228
ON history 0.038 0.272 to 0.349 0.910
Corrected P values that represent strong, good, or mild evidence of
difference between MS patients and normative data are highlighted
with bold text. A total of 63 eyes from 32 MS patients were analyzed,
along with 49 eyes from 49 healthy individuals.
TABLE 6. Results of GEE models for MF-ERG amplitude (AMP) and
peak time (PEAK) Variables Over Five Concentric Rings According to
MS Status (MS Versus Healthy) and ON History (Positive Versus
Negative), Adjusted for Age and Including Coefficients, 95%-Wald CIs of
the Coefficients, and Corrected P Values (Benjamini-Hochberg)
MF-ERG
Variable Covariate Coefficient 95% CI
P,
Corrected
Ring 1 AMP MS status 1.138 4.315 to 6.590 0.803
ON history 2.541 7.953 to 2.870 0.643
Ring 1 PEAK MS status 0.255 0.312 to 0.823 0.536
ON history 0.370 0.381 to 1.122 0.643
Ring 2 AMP Category 0.496 2.192 to 3.184 0.803
ON history 0.194 1.294 to 1.682 0.910
Ring 2 PEAK MS status 0.609 0.023 to 1.195 0.087
ON history 0.359 0.250 to 0.969 0.643
Ring 3 AMP MS status 0.244 1.217 to 1.704 0.803
ON history 0.794 0.355 to 1.944 0.530
Ring 3 PEAK MS status 0.686 0.143 to 1.229 0.040
ON history 0.224 0.089 to 0.537 0.530
Ring 4 AMP MS status 0.552 0.484 to 1.589 0.471
ON history 0.349 0.703 to 1.402 0.746
Ring 4 PEAK MS status 0.624 0.083 to 1.165 0.057
ON history 0.144 0.261 to 0.548 0.746
Ring 5 AMP MS status 0.109 0.839 to 1.056 0.854
ON history 0.015 0.765 to 0.795 0.970
Ring 5 PEAK MS status 0.758 0.218 to 1.298 0.023
ON history 0.136 0.300 to 0.572 0.746
Corrected P values that represent strong, good, or mild evidence of
difference between MS patients and normative data are highlighted
with bold text. A total of 61 eyes from 31 MS patients were analyzed,
along with 36 eyes from 36 healthy individuals.
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FIGURE 2. (a–h) Boxplots showing ERG peak time (PEAK) and amplitude (AMP) results in MS patients. For brevity, only those parameters in which
strong, good, or mild evidence of a difference between MS patients and normal values are displayed; the data for all parameters are shown in Table 2.
Leftmost bars show preexisting clinical normative values (Normal), followed by results from MS eyes without a history of ON (MS ON), MS
patients with a history of ON (MSþON), and all MS eyes (MS [all]). For each bar, the number of eyes analyzed (n) is displayed. On each plot, the
corrected P value resulting from the comparison of the MS cohort with normative data is displayed. Median values and interquartile ranges (IQRs)
are indicated by horizontal lines and boxes, respectively; whiskers show the lowest and highest data points still within 1.5 IQR of the lower and
upper quartiles. Individual data points are represented by gray dots. Peak times are displayed in milliseconds, amplitudes in microvolts.
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underlying these abnormalities; however, the lack of any
observed differences in eyes with and without previous ON
(with the caveat that the power of our analysis may be reduced
due to the relatively small size of the MS ON subgroups)
suggests that retrograde transsynaptic degeneration conse-
quent to inflammation and demyelination of the optic nerve as
a source of the functional deficits described here is unlikely.
This is reinforced by previous studies showing abnormal ERG
findings in MS patients without previous ON,11 and suggesting
that retrograde transsynaptic degeneration in MS does not
affect the INL or more distal layers.36 The absence of myelin in
human retinae, confirmed in our entire cohort by ophthalmo-
logic examination, also suggests that an autoimmune response
to myelin antigens is unlikely as a potential mediator of the
changes described here. Given that glutamate is the most
prevalent neurotransmitter throughout the retina and visual
pathway,37 and that the glutamergic pathway is frequently
dysfunctional in MS,38 glutamergic abnormalities could be
considered as a possible explanation for outer retinal
dysfunction in our cohort; further studies would be needed
to confirm or exclude this possibility.
Despite the results showing evidence of retinal dysfunction
in MS patients, OCT analysis showed no significant differences
between patients and normative values for any of the analyzed
retinal layers or complexes. This may be due to reduced
statistical power consequent to the relatively low number of
patients examined in the present study, as previous work with
FIGURE 3. (a–d) Boxplots showing MF-ERG P1 peak time (PEAK) results in MS patients. For brevity, only those parameters in which strong, good, or
mild evidence of a difference between MS patients and normative data are displayed; the data for all parameters are shown in Table 3. Leftmost bars
show preexisting clinical normative values (Normal), followed by results from MS eyes without a history of ON (MSON), MS patients with a history
of ON (MSþON), and all MS eyes (MS [all]). For each bar, the number of eyes analyzed (n) is displayed. On each plot, the corrected P value resulting
from the comparison of the MS cohort with normative data is displayed. Median values and IQRs are indicated by horizontal lines and boxes,
respectively; whiskers show the lowest and highest data points still within 1.5 IQR of the lower and upper quartiles. Individual data points are
represented by gray dots. P1 peak times are displayed in milliseconds. Note that all P values pertaining to MF-ERG amplitude (AMP) variables were
nonsignificant, and thus no MF-ERG AMP plots are displayed.
TABLE 7. Results of GEE Models for OCT Variables According to MS
Status (MS Versus Healthy) and ON History (Positive Versus Negative),
Adjusted for Age and Including Coefficients, 95%-Wald CIs of the
Coefficients, and Corrected P Values (Benjamini-Hochberg)
OCT
Variable Covariate Coefficient 95% CI
P,
Corrected
RNFL-G MS status 0.697 3.302 to 4.697 0.977
ON history 16.492 25.151 to 7.833 <0.001
RNFL-T MS status 2.911 8.341 to 2.520 0.683
ON history 18.402 27.248 to 9.556 <0.001
RNFL-PMB MS status 1.917 5.867 to 2.033 0.683
ON history 14.667 20.799 to 8.534 <0.001
GC-IPL MS status 0.002 0.034 to 0.030 0.984
ON history 0.164 0.226 to 0.101 <0.001
INL MS status 0.004 0.019 to 0.011 0.946
ON history 0.012 0.001 to 0.023 0.053
OPL MS status 0.000 0.016 to 0.016 0.984
ON history 0.017 0.003 to 0.037 0.117
ONL MS status 0.027 0.062 to 0.008 0.528
ON history 0.002 0.019 to 0.022 0.884
PR MS status 0.011 0.021 to 0.001 0.190
ON history 0.007 0.001 to 0.015 0.117
Corrected P values that represent strong, good, or mild evidence of
difference between MS patients and normative data are highlighted
with bold text. A total of 61 eyes from 31 MS patients were analyzed,
along with 38 eyes from 38 healthy individuals.
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FIGURE 4. (a–h) Boxplots showing OCT results in MS patients. Leftmost bars show preexisting clinical normative values (Normal), followed by
results from MS eyes without a history of ON (MSON), MS patients with a history of ON (MSþON), and all MS eyes (MS [all]). For each bar, the
number of eyes analyzed (n) is displayed. On each plot, the corrected P value resulting from the comparison of the MS cohort with normative data is
displayed. Median values and IQRs are indicated by horizontal lines and boxes, respectively; whiskers show the lowest and highest data points still
within 1.5 IQR of the lower and upper quartiles. Individual data points are represented by gray dots. Circumpapillary RNFL-G, RNFL-T, and RNFL-
PMB thickness values are given in microns, whereas volumes for the remaining retinal layers and complexes over the 1-, 2.22-, and 3.45-mm ETDRS
grid are given in cubic millimeters.
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considerably larger cohorts has documented inner retinal
thinning in MS patients.10,36 Despite this caveat, our findings
regarding the outer retina are essentially confirmed by a recent
meta-analysis comparing retinal layer thicknesses in MS eyes
with and without previous ON with healthy control subjects.39
After pooling data from multiple studies and many eyes (with
individual MS subgroups ranging in size from 321 to 695 eyes),
this analysis found that combined OPL-ONL thickness appears
indistinguishable from normal in MS eyes both with and
without previous ON, whereas MS eyes with previous ON had
OPL-ONL thickness approximately 1 lm thicker than MS eyes
without previous ON.39 INL thickness also appears normal in
MS eyes without previous ON,39 as in the present study. When
comparing eyes with previous ON to those without, we found
strong evidence for reduction of RNFL thickness (RNFL-G,
RNFL-T, and RNFL-PMB) and GCL-IPL volume, as expected
based on previous reports,39–41 as well as mild evidence for
increased INL volume, as described elsewhere.39
Of particular interest was that no volume differences of the
INL and outer retinal layers were observed between MS
patients and normative data, despite these layers being the
presumed origin of many of the abnormal ERG responses that
were documented; in other words, we observed no structural
changes corresponding to the measured functional abnormal-
ities. There are at least two possible reasons for this apparent
discrepancy. First, recent research into the INL has suggested
that its volume in MS patients is dynamic; untreated patients
had significantly thicker INL than healthy subjects, which
remained constant in those patients who commenced ineffec-
tive therapy but normalized in those patients in whom therapy
was effective (as evidenced by no clinical relapses or new MRI
lesions during the follow-up period).9 Alternatively, other
authors have proposed that MS patients may exhibit thinning
of the INL.10,42 In our study, the wide range of INL volumes in
both the normative data and patient cohort may have
contributed to the lack of detectable differences between the
two groups (Fig. 3e). Additionally, the electroretinographic
abnormalities we recorded may reflect simply dysfunction of
the corresponding cells, rather than atrophy, which would be
more likely to be evidenced by reduced volume/thickness on
OCT (e.g., as in the case of atrophy and thinning of retinal
ganglion cells after ON19). Dysfunction also may be more
compatible with the relatively subtle nature of the ERG
changes documented here. An additional consideration is that
TABLE 8. Results of GEE Models Quantifying the Influence of Retinal Structure and Previous ON on ERG Amplitudes (AMP) and Peak Times (PEAK)
in MS Patients, Adjusted for Age and Including Coefficients, 95%-Wald CIs of the Coefficients, and Corrected P Values (Benjamini-Hochberg)
ERG Variable Covariate Coefficient 95% CI P, Corrected
Rod-cone a-wave AMP INL 392.057 745.048 to 39.065 0.118
ONL 370.087 572.005 to 168.168 0.001
PR 175.531 950.464 to 599.401 0.876
ON history 27.259 3.523 to 50.996 0.098
Rod-cone a-wave PEAK INL 0.754 2.891 to 4.399 0.685
ONL 0.556 1.064 to 2.176 0.610
PR 2.778 8.386 to 2.831 0.876
ON history 0.131 0.278 to 0.015 0.159
Cone a-wave AMP INL 20.571 103.985 to 62.843 0.685
ONL 55.745 97.764 to 13.727 0.019
PR 5.264 174.944 to 185.472 0.954
ON history 0.610 4.727 to 5.947 0.823
Cone a-wave PEAK INL 1.549 3.495 to 6.593 0.685
ONL 0.746 2.120 to 3.612 0.610
PR 1.810 7.940 to 4.319 0.876
ON history 0.142 0.341 to 0.058 0.218
Rod b-wave AMP INL 192.965 420.627 to 806.557 0.663
OPL 2.947 459.671 to 453.778 0.990
ON history 12.964 44.388 to 18.461 0.620
Rod b-wave PEAK INL 15.870 68.226 to 36.487 0.663
OPL 6.621 50.023 to 36.781 0.918
ON history 0.093 3.801 to 3.986 0.963
Rod-cone b-wave AMP INL 649.359 120.175 to 1178.544 0.049
OPL 410.882 1011.008 to 189.244 0.359
ON history 19.616 64.295 to 25.062 0.620
Rod-cone b-wave PEAK INL 6.927 5.942 to 19.795 0.583
OPL 9.915 21.977 to 2.146 0.359
ON history 0.580 0.152 to 1.312 0.392
Cone b-wave AMP INL 221.501 74.825 to 368.176 0.018
OPL 69.846 283.202 to 143.510 0.782
ON history 3.636 14.626 to 7.354 0.620
Cone b-wave PEAK INL 1.467 5.865 to 8.798 0.695
OPL 2.226 5.031 to 0.580 0.359
ON history 0.213 0.063 to 0.489 0.392
The effect of ONL, PR, and INL on ERG a-waves and of INL and OPL on ERG b-waves and flicker responses is analyzed; this reflects current
knowledge of the likely cellular origins of ERG components (see main text for details). Corrected P values that represent strong, good, or mild
evidence of difference between MS patients and normative data are highlighted with bold text. A total of 61 eyes from 31 MS patients were analyzed
for the models quantifying the influence of retinal structure and previous ON on the ERG. All P values pertaining to the influence of retinal structure
and previous ON on the MF-ERG were nonsignificant (after analyzing 59 eyes from 30 MS patients) and are omitted for brevity (see main text for
details).
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the ERG reflects the response of the entire retina, whereas the
OCT outcome measures are derived from an area of central
retina approximately 128 in diameter, and so we cannot
exclude the possibility that the retinal dysfunction described
here disproportionately affects the peripheral retina.
Analysis of the relationships between ERG parameters and
their presumed cellular origins in MS patients showed good to
strong evidence of an association between rod/cone and cone
ERG a- and b-wave amplitudes and the ONL and INL,
respectively. Given that our data show that ERG peak times
are more likely than amplitudes to be abnormal in MS, the lack
of correlation between OCT findings and ERG peak times
could be considered surprising. However, this is consistent
with dysfunctional, but not atrophic, bipolar cells and
photoreceptors. No significant associations were found be-
tween MF-ERG and OCT findings despite the MF-ERG stimulus
being closer in size to the OCT ETDRS grid (although still
approximately four times larger) than the pan-retinal ERG
stimulus. Given our results, it is likely that the ERG (rather than
MF-ERG) is the more sensitive method for detecting outer
retinal dysfunction in MS patients.
Based on the results of the cross-sectional analysis presented
here and recent work suggesting that ERG amplitudes (but not
peak times) are influenced by electrode placement,43 we
propose to focus our eventual longitudinal data analysis on the
electrophysiological time-to-peak values rather than response
amplitudes. Reducing the number of variables analyzed will also
serve to increase the statistical power of future analyses, an
important consideration given the large number of variables
generated by an electrophysiological test battery.
Our study has clear limitations, namely the lack of a formally
enrolled cohort of control subjects and the relatively low
number of MS patients examined (n¼ 32). The duration of the
study visits (up to 4.5 hours) and the longitudinal nature of the
study made the recruitment of a specific cohort of healthy
subjects unfeasible. The clinical normative values used had the
advantage of being acquired before commencing the present
study, preventing any possibility of selection bias. Mitigating
against our modestly sized patient cohort, our use of GEE for
statistical analysis enabled us to include both eyes of most MS
patients in the analysis (due to the model accounting for
intereye correlations of within-subject measurements17), an
approach that ensured the actual number of eyes analyzed
exceeded those examined in other studies12 and avoided
potential statistical issues caused by analyzing both eyes of MS
patients without controlling for such intereye correlations.11,34
In summary, we have shown changes to outer retinal
function in patients with MS and CIS, without detectable
structural abnormality of the relevant retinal layers. Our data
show that structurally normal retinae cannot be assumed to be
functionally normal in MS patients. The changes are relatively
subtle; however, most of our patients also had early or benign
disease (as evidenced by the median EDSS score of 1.0).
Further cross-sectional studies with a larger cohort including
more severely affected patients will be necessary to confirm
whether the degree of retinal dysfunction is related to the
severity of disease activity. Analysis of electrophysiological
peak times, rather than response amplitudes, may be the most
promising approach for future work.
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